Bausch & Lomb (Rochester, N.Y.) recently announced the U.S. launch of its new Akreos MICS lens, a foldable intraocular lens (IOL) designed for implantation through a 1.8 mm incision during phacoemulsification cataract surgery.
The ability to insert the new acrylic lens through such a small incision offers several potential advantages, including faster healing and less surgically-induced astigmatism, according to the company.
The lens also features aspheric optics designed to reduce spherical aberration and produce excellent post-operative vision. (Spherical aberration is a common higher-order aberration that can degrade vision and cause glare and halos around lights.)
The new Akreos IOL represents a new level of micro-incision cataract surgery (MICS). With most other IOLs used in MICS, an incision of 2.2 mm to 2.75 mm is required.
Prior to phacoemulsification technology, incision sizes of 10 mm or greater were common in cataract surgery, with greater risks of eye infection, delayed healing and other cataract surgery complications.
Because the Akreos MICS lens is a premium IOL, it may increase your cataract surgery cost if you choose this implantable lens for your surgery.
The Akreos MICS is the latest addition to Bausch & Lomb’s Akreos line of IOLs. First introduced in Europe over 10 years ago, more than 3 million Akreos IOLs have been implanted worldwide, according to the company.
Tags: Akreos, Cataract Surgery Complications, intraocular lenses, IOLs, phacoemulsification